Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin plus budesonide to prevent restenosis after interventional treatment of benign traumatic or infectious airway stenosis
ChiCTR2400082421Phase 4Not yet recruiting
- Sponsor
- Tangdu Hospital
- Start
- Mar 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of erythromycin and budesonide in airway stenosis (2 arms), sponsored by Tangdu Hospital. Primary endpoint: Degree of airway stenosis. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
erythromycinbudesonide
03
Conditions
airway stenosis
Beyond the preview
Go deeper on ChiCTR2400082421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082421.